E PIAF

Enhanced Protective Immunity Against Filariasis

 Coordinatore THE UNIVERSITY OF EDINBURGH 

 Organization address address: OLD COLLEGE, SOUTH BRIDGE
city: EDINBURGH
postcode: EH8 9YL

contact info
Titolo: Ms.
Nome: Angela
Cognome: Noble
Email: send email
Telefono: +44 131 650 9024
Fax: +44 131 651 9023

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 6˙634˙715 €
 EC contributo 5˙000˙000 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2009-single-stage
 Funding Scheme CP-FP-SICA
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-03-01   -   2014-08-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    THE UNIVERSITY OF EDINBURGH

 Organization address address: OLD COLLEGE, SOUTH BRIDGE
city: EDINBURGH
postcode: EH8 9YL

contact info
Titolo: Ms.
Nome: Angela
Cognome: Noble
Email: send email
Telefono: +44 131 650 9024
Fax: +44 131 651 9023

UK (EDINBURGH) coordinator 1˙449˙784.00
2    THE UNIVERSITY OF LIVERPOOL

 Organization address address: Brownlow Hill, Foundation Building 765
city: LIVERPOOL
postcode: L69 7ZX

contact info
Titolo: Ms.
Nome: Suzanne
Cognome: Halpin
Email: send email
Telefono: +44 151 7948725
Fax: +44 151 7948728

UK (LIVERPOOL) participant 610˙912.00
3    UNIVERSITAETSKLINIKUM BONN

 Organization address address: Sigmund-Freud-Strasse 25
city: BONN
postcode: 53105

contact info
Titolo: Ms.
Nome: Beate
Cognome: Becker
Email: send email
Telefono: +49 228 287 19454
Fax: +49 228 287 14635

DE (BONN) participant 559˙670.00
4    MUSEUM NATIONAL D'HISTOIRE NATURELLE

 Organization address address: RUE CUVIER 57
city: PARIS
postcode: 75005

contact info
Titolo: Dr.
Nome: Coralie
Cognome: Martin
Email: send email
Telefono: +33 1 40793496
Fax: +33 1 40793499

FR (PARIS) participant 489˙316.00
5    EBERHARD KARLS UNIVERSITAET TUEBINGEN

 Organization address address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074

contact info
Titolo: Prof.
Nome: Peter
Cognome: Soboslay
Email: send email
Telefono: +49 7071 2980230
Fax: +49 7071 295996

DE (TUEBINGEN) participant 478˙516.00
6    Fios Genomics Limited

 Organization address address: Buchanan Street 166
city: Glasgow
postcode: G1 2LS

contact info
Titolo: Dr.
Nome: Gary
Cognome: Rubin
Email: send email
Telefono: 441315000000
Fax: 441317000000

UK (Glasgow) participant 400˙000.00
7    Research Foundation in Tropical Diseases and Environment

 Organization address address: University Street
city: Buea
postcode: 474

contact info
Titolo: Dr.
Nome: Ayuk Peter
Cognome: Enyong
Email: send email
Telefono: +237 77754101
Fax: +237 33323109

CM (Buea) participant 348˙898.00
8    Kwame Nkrumah University of Science and Technology

 Organization address address: "Private Mail Bag, University Post Office"
city: Kumasi
postcode: Ash

contact info
Titolo: Mr.
Nome: Sabastian
Cognome: Kankam
Email: send email
Telefono: +23 351 60531
Fax: +23 351 62017

GH (Kumasi) participant 227˙304.00
9    INSTITUT DE RECHERCHE AGRICOLE POUR LE DEVELOPPEMENT

 Organization address address: PO BOX
city: YAOUNDE
postcode: N/A

contact info
Titolo: Dr.
Nome: Vincent Ngwang
Cognome: Tanya
Email: send email
Telefono: +237 7776 9083
Fax: +237 2223 7720

CM (YAOUNDE) participant 220˙176.00
10    INSTITUT NATIONAL D'HYGIENE

 Organization address address: RUE NANGBETO
city: LOME
postcode: 1396

contact info
Titolo: Prof.
Nome: Meba
Cognome: Banla
Email: send email
Telefono: +228 550 0954

TG (LOME) participant 215˙424.00
11    UNIVERSITY OF GLASGOW

 Organization address address: University Avenue
city: GLASGOW
postcode: G12 8QQ

contact info
Titolo: Mr.
Nome: Joe
Cognome: Galloway
Email: send email
Telefono: 441413000000

UK (GLASGOW) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

validation    vaccine    health    central    filarial    bioinformatics    treatment    regulation    protective    onchocerciasis    bancrofti    computer       loa    infections    ivermectin    co    mechanisms    expression    influence    africa    west    responses    public    assimilations    immunity    worm   

 Obiettivo del progetto (Objective)

'Filarial infections remain a major public health problem in West and Central Africa. Three filarial species are involved: Onchocerca volvulus (onchocerciasis or river blindness); Wuchereria bancrofti (lymphatic filariasis); and Loa loa (the eye worm). Treatment of onchocerciasis with ivermectin has been successful in many situations but emergence of drug resistance and risk of severe adverse reactions associated with L loa co-infections is restricting the implementation of mass treatment and consequently alternate approaches to control are required. Studies with animal models have identified the general mechanisms of protective immunity while human studies have drawn attention to immune regulatory processes that influence clinical presentations Together, these observation provide a basis for vaccine development. The next challenge is to identify target antigens and ensure appropriate formulation and delivery to promote protective responses and avoid any pathology. This project aims to: 1, use transciptomics and bioinformatics to identify the parasite molecules that are targets of protective immunity and that may influence the regulation of such responses; and 2, microarray technologies and bioinformatics to determine the pathways that lead to expression of protective immunity. Cohorts of onchocerciasis patients who have received treatment with ivermectin or tetracycline, or are co infected with either W bancrofti or L loa provide both input to the pathway studies and a means of validation of the computer assimilations. Confirmation of the mechanisms and targets of protective immunity and validation of computer assimilations will also be investigated using the O ochengi-cattle model that also enables experimentation under natural challenge. Litomosoides sigmodontis in mice provides a robust and rapid validation of results obtained from computation relating to expression and regulation of protective responses and a primary system for screening vaccine candidates'

Introduzione (Teaser)

Despite available therapies, parasitic worm infections remain a threat to public health in west and central Africa. EU-funded scientists are working hard to develop new treatments using an innovative approach that considers all the biological systems involved.

Altri progetti dello stesso programma (FP7-HEALTH)

TINN2 (2011)

Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates

Read More  

COGS (2009)

Collaborative Oncological Gene-environment Study

Read More  

SYBILLA (2008)

Systems Biology of T-cell Activation in Health and Disease

Read More